Home > Insider Trading > Filing (0001593968-15-000074)

Filing Details

Accession Number:: 0001593968-15-000074
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-03-13 17:22:36
Reporting Period:: 2015-03-11

Filing Date:: 2015-03-13
Accepted Time:: 2015-03-13 16:22:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
749660	Icad Inc	ICAD	Surgical & Medical Instruments & Apparatus (3841)	020377419

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1508910	Somu Subramaniam	98 Spit Brook Rd. Ste. 100 Nashua NH 03062		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-03-11	31,733	$9.20	230,126	No	4	S	Indirect	NSV
Common Stock	Disposition	2015-03-12	19,029	$9.28	211,097	No	4	S	Indirect	NSV
Common Stock	Disposition	2015-03-12	64,969	$0.00	146,128	No	4	J	Indirect	NSV
Common Stock	Disposition	2015-03-12	23,530	$0.00	122,598	No	4	J	Indirect	NSV

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	NSV
No	4	S	Indirect	NSV
No	4	J	Indirect	NSV
No	4	J	Indirect	NSV

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,000	Direct

Footnotes

The reported securities were executed in multiple trades with prices ranging between $9.13 and $9.46. The reporting person hereby undertakes to provide, upon request, to the SEC Staff, the Issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
Mr. Subramaniam is a principal of NSV Management, LLC, and NSV Partners, LLC, the investment manager and general partner, respectively, of New Science Ventures Fund 1 - Madison, LP, which owns shares of Common Stock, par value $0.01 per share (the Common Stock) of iCAD, Inc.
The reported securities were executed in multiple trades with prices ranging between $9.25 and $9.34. The reporting person hereby undertakes to provide, upon request, to the SEC Staff, the Issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.
Mr. Subramaniam is a principal of NSV Management, LLC, and NSV Partners, LLC, the investment manager and general partner, respectively, of New Science Ventures Fund 1 Euro, LP, which owns shares of Common Stock, par value $0.01 per share (the Common Stock) of iCAD, Inc. New Science Ventures Fund 1 Euro, LP, made a private distribution of 64,969 shares to its Investors, such distribution representing the Investors' pro rata share of the Common Stock owned by the holder.
Mr. Subramaniam is a principal of NSV Management, LLC, and NSV Partners, LLC, the investment manager and general partner, respectively, of Bedford BioPartners, LP, which owns shares of Common Stock, par value $0.01 per share (the Common Stock) of iCAD, Inc. Bedford BioPartners, LP, made a private distribution of 23,530 shares to its Investors, such distribution representing the Investors' pro rata share of the Common Stock owned by the holder.